Description

MONTRELIEF LC TAB is a clinically effective anti-allergy formulation composed of Montelukast 10 mg, a leukotriene receptor antagonist, and Levocetirizine 5 mg, a third-generation non-sedating antihistamine. This combination helps alleviate both upper respiratory and skin-related allergic symptoms by targeting multiple pathways of allergic response.

Montelukast works by blocking leukotrienes — inflammatory chemicals involved in asthma and allergies — thereby reducing bronchial inflammation, congestion, and other respiratory symptoms.

Levocetirizine, a potent H1-receptor blocker, reduces symptoms like sneezing, nasal discharge, watery eyes, and skin rashes without causing significant drowsiness.

This combination is widely used for:

• Seasonal and perennial allergic rhinitis

• Chronic idiopathic urticaria (hives)

• Bronchial asthma adjunct therapy

• Sneezing, nasal congestion, and watery eyes

• Itchy skin and rashes

Manufactured in WHO-GMP and ISO-certified facilities, MONTRELIEF LC TAB is exported by BLUEPILL EXPRESS, a globally trusted name in pharmaceutical manufacturing and export. The product is available for international distribution across Asia, Africa, the Middle East, Latin America, and Europe, with full regulatory and logistic support.